Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. - Wikidata - wikimedia - TriplyDB

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

http://www.wikidata.org/entity/Q34334920

about

Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors Chemotherapy-related cognitive impairment in older patients with cancer American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline Cancer- and cancer treatment-associated cognitive change: an update on the state of the science A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation Postoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the Elderly Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).Cognitive function and breast cancer: promise and potential insights from functional brain imaging.Functional MRI studies in non-CNS cancers.Default mode network as a potential biomarker of chemotherapy-related brain injury Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?Verbal fluency in breast cancer patients treated with chemotherapy.Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen.Functionality in Women with Breast Cancer: The Use of International Classification of Functioning, Disability and Health (ICF) in Clinical Practice Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Prevalence, mechanisms, and management of cancer-related cognitive impairment.Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.A meta-analysis of cognitive impairment following adult cancer chemotherapy.Determining chemotherapy tolerance in older patients with cancer.Altered small-world properties of gray matter networks in breast cancer Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review.Cognitive function and fatigue after diagnosis of colorectal cancer Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.Neurocognitive dimensions of breast cancer and its treatment Breast cancer survivorship issues.A Brief Patient Self-Report Screening Measure of Cancer Treatment-Related Memory Problems: Latent Structure and Reliability Analysis An update on cancer- and chemotherapy-related cognitive dysfunction: current status.Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research.Prefrontal cortex and executive function impairments in primary breast cancer.Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer

P2860

Q24594173-21D81EFF-32E3-42F3-9E1D-528955990A27 Q26747612-E4D6EA9A-88A5-466F-804D-E634870E386B Q26773986-8F65D8F8-61F3-4CCF-8C94-26BE2802EA8F Q26853289-393196E6-3086-4964-8E00-8AEC6F3195FE Q27013566-279C3E83-3FC6-4089-9459-25C195A4EEF0 Q28086981-3454D985-C5FB-4D11-9202-B41506919B56 Q30390049-E3057BA1-29DB-4EFB-BF32-02D5E31F5F60 Q30489606-78CF4E7A-D01F-44E9-963A-9975ACAD398F Q30572890-C4FAC707-B5E8-4F48-BE98-DC668F41352A Q30660824-AF941E06-99CE-4F21-9475-3ED995602C9E Q30830124-F67B76E5-ECBC-4FCF-826B-4F80ABE18E3C Q31155370-5CBA1D82-A61F-4EF2-9E37-21553DDF21CF Q33575742-F8EA07BB-5D05-4B49-857A-4CB461B5ACD3 Q33590378-814E789E-59AA-409B-9223-157E06ABBE08 Q33636517-1AA3FDAA-A44D-4E3B-8EAA-9A026F16C886 Q33717889-542BA9C8-5A2B-4171-9A8D-EEBFA6B0D4B9 Q33729085-71A1F386-DA64-4A8C-8AAA-DD77C675000C Q33854977-99326044-EE4E-47D6-BBFC-6F84BAA2E63F Q33907387-5A288142-1BE0-418B-A6AE-30E3B7A1A9D6 Q34031141-A5D676F3-EBF4-469E-A2AE-A7E1E4FC3A6B Q34083459-0099C842-05C0-44B1-875C-CE83669D4381 Q34155010-4679D799-C746-460D-A7E3-148651A9F96C Q34282795-9359A547-9D25-4CF3-AB4E-12024A34DBAA Q34395112-F2E95322-43CF-4A43-A507-8CD39F2A516C Q34402534-19EED134-3155-433C-8B63-CFA4705464BD Q34429393-FBAA64FF-F9F7-4CCF-BB97-FDB69B8B5687 Q34553351-CC70AFFF-0B28-460D-91A3-C59913B50FA7 Q34553654-0714A474-8637-419C-9FEF-7F114B72E76B Q34633028-48177AC3-C42C-4F3A-BDE0-20C75B76D6F7 Q34661127-83FCD699-E7BC-4AF4-BD48-0953D7180397 Q34895561-11A5043B-B04A-4CAA-8537-0EBAA8FF2FDD Q35037127-D9AE52D4-E5AC-4051-979D-F836ED5DDF80 Q35059702-242CE88B-E081-494A-9054-7F22460B40EF Q35067446-85E13713-70E7-47B2-A3D7-3949840003DF Q35164117-15FE7F0C-53F9-4D54-8CCB-912AB804085A Q35446931-534F75F9-B6EB-4C8E-8602-1808CAB54E1C Q35556085-B4C76C4F-02C1-4135-B017-0A0751DF5C31 Q35617310-14C08DC5-C369-4952-996E-16828D280E85 Q35708734-85E9728E-1F48-413F-8DFB-AB34E7A7E219 Q35732380-C36350F9-6434-4866-BF52-A849AE26EC3B

P2860

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

http://www.wikidata.org/entity/Q34334920

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Longitudinal assessment of cog ...... of age and cognitive reserve.

@ast

Longitudinal assessment of cog ...... of age and cognitive reserve.

@en

Longitudinal assessment of cog ...... of age and cognitive reserve.

@nl

type

label

Longitudinal assessment of cog ...... of age and cognitive reserve.

@ast

Longitudinal assessment of cog ...... of age and cognitive reserve.

@en

Longitudinal assessment of cog ...... of age and cognitive reserve.

@nl

prefLabel

Longitudinal assessment of cog ...... of age and cognitive reserve.

@ast

Longitudinal assessment of cog ...... of age and cognitive reserve.

@en

Longitudinal assessment of cog ...... of age and cognitive reserve.

@nl

P1433

Q34334920-586CE5BB-EC02-4FE7-B128-B4EBBF1EC27B

P1476

Q34334920-E3408FB8-ACF8-41D9-AABD-CC0C60BE31F2

P2093

Q34334920-0B7FB6CF-A3F1-4149-B72E-33E7FE2DEE1C

Q34334920-148D4FEF-8712-401F-ACAF-A2CAA3CF3101

Q34334920-21250316-DDF0-41FD-8734-20A95E11761F

Q34334920-7CCF7B5F-2D52-441B-880D-4CB621659BC8

Q34334920-B6E468D4-9713-4395-9131-16C5625475F7

Q34334920-DAD25903-297D-47B5-BF55-A33F2182A097

Q34334920-FBB6E894-F0A5-425A-A2EF-1E4EC5324BC6

P2860

Q34334920-1E25071F-DB4B-4B7D-9DF3-3AA7D02B7FF8

Q34334920-2A23C39A-F420-496D-B36B-46C78ED852CA

Q34334920-32090003-C850-4021-A115-FBE422C2E88D

Q34334920-3B9B873E-ED47-4FBD-A901-83F47C5142FC

Q34334920-4E71981B-73BE-4644-B214-237E396F6A95

Q34334920-5A8A176B-4917-43F7-9FF1-956636407682

Q34334920-6B6257F5-A955-4967-83D4-BDD8D6F6620D

Q34334920-72026C11-644B-46AA-9BA2-8EF875FD71C8

Q34334920-7C7D4853-23CF-4F18-80AF-627C36DA0775

Q34334920-8049F461-98BF-4A90-A921-8022761B84BF

P304

Q34334920-F9BDC1DD-878A-489C-8FFA-A5C86E222438

P31

Q34334920-C3640C88-F32E-4102-9982-1467F2BB630A

P356

Q34334920-9B8C2BC2-63B2-48E1-9C65-BFD3C538FF0A

P407

Q34334920-7DEB999C-2727-4FAF-B0B8-A939F7217177

P433

Q34334920-A893A84E-FF72-4C5C-92EC-4B129D9FF06E

P478

Q34334920-A8EC2CEF-3FB7-47BC-9401-4ED62F7FFDB9

P50

Q34334920-EB13F72C-65FD-4B78-BE62-0175B510BBBA

Q34334920-F1100FE8-E5D3-42B9-BFFD-5DA1045A5B54

P577

Q34334920-EEFF689A-934D-4C54-96B9-265973BFD72C

P5875

Q34334920-7CAE8E86-1274-44F1-8387-1CB8D0252449

P698

Q34334920-9B76B943-4F98-4027-8CAB-0AF9D10C2ABA

P932

Q34334920-3530B0CC-DACE-495A-9620-C5687486D576

P356

JCO.2009.27.0827

P1433

Journal of Clinical Oncology

P1476

Longitudinal assessment of cog ...... of age and cognitive reserve.

@en

P2093

Brett S Hanscom

http://www.w3.org/2001/XMLSchema#string

Charlotte T Furstenberg

http://www.w3.org/2001/XMLSchema#string

Gary N Schwartz

http://www.w3.org/2001/XMLSchema#string

Peter A Kaufman

http://www.w3.org/2001/XMLSchema#string

Tamsin J Mulrooney

http://www.w3.org/2001/XMLSchema#string

Tim A Ahles

http://www.w3.org/2001/XMLSchema#string

Yuelin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Renaming "chemobrain"

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

Random-effects models for longitudinal data

What is cognitive reserve? Theory and research application of the reserve concept

'Chemobrain' in breast carcinoma?: a prologue.

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

Cognitive reserve and the neurobiology of cognitive aging.

Cognitive function in breast cancer patients prior to adjuvant treatment

Candidate mechanisms for chemotherapy-induced cognitive changes.

Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.

P304

4434-4440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.27.0827

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Andrew J. Saykin

Brenna C. McDonald

P577

2010-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46255888

http://www.w3.org/2001/XMLSchema#string

P698

20837957

http://www.w3.org/2001/XMLSchema#string

P932

2988635

http://www.w3.org/2001/XMLSchema#string